Accessibility Menu

National Health Investors(FRA) WX6

Market Cap€3.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€57.50
-5.74%
-3.50Today

National Health Investors Financials at a Glance

Market Cap

€3.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€373.14

Net Income (TTM)

€141.71

EPS (TTM)

€2.96

P/E Ratio

20.58

Dividend

€3.17

Beta (Volatility)

-0.01 (Low)

Price

€57.50

Volume

0

Open

€57.50

Previous Close

€61.00

Daily Range

€57.50 - €57.50

52-Week Range

€57.50 - €76.50

Estimated Earnings Date

N/A

WX6 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About National Health Investors

National Health Investors, Inc. engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. It operates through the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments. The Real Estate Investments segment includes real estate investments and lease, mortgage, and other notes receivables in independent living facilities. The SHOP segment is involved in two ventures that own the operations of independent living facilities. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.

Industry

Health Care REITs

Employees

32

CEO

D. Eric Mendelsohn

WX6 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

10.85%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.86%

Dividend Yield

5.20%

Payout Ratio

N/A

Stock Overview

Market Cap

€3.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

49.11M

Volume

0

Avg. Volume

8.667

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

National Health Investors Performance Analysis

National Health Investors annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 271,889,6139.9%
20232023-12-31EUR 298,169,7799.7%
20242024-12-31EUR 312,542,1924.8%
20252025-12-31EUR 335,403,5057.3%
National Health Investors annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.41-31.8%
20232023-12-31EUR 2.89104.9%
20242024-12-31EUR 2.89-0.0%
20252025-12-31EUR 2.67-7.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€105.06

+1.3%

Gross Profit

€50.98

+1.0%

Gross Margin

48.52%

+0.8%

Market Cap

€3.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€101.49

N/A

Employees

32

N/A

Net Income

€47.53

+1.5%

EBITDA

€65.90

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.14K

+18.1%

Total Debt

€1.12K

+1.2%

Accounts Receivable

N/A

N/A

Inventory

€0.00

N/A

Long Term Debt

€1.12K

+1.5%

Short Term Debt

€0.13

+0.0%

Return on Assets

5.85%

+1.0%

Return on Invested Capital

5.04%

N/A

Free Cash Flow

€49.06

+1.0%

Operating Cash Flow

€56.16

+1.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
BITOProShares Trust - ProShares Bitcoin ETF
$10.63+0.02%
INTCIntel
$89.51+0.00%

Questions About WX6

What is the current price of National Health Investors?

National Health Investors is trading at €57.50 per share.

What is the 52-week range for National Health Investors?

Over the past 52 weeks, National Health Investors has traded between €57.50 and €76.50.

How much debt does National Health Investors have?

As of the most recent reporting period, National Health Investors reported total debt of €1.12B.

How much cash does National Health Investors have on hand?

National Health Investors reported €26.58M in cash and cash equivalents in its most recent financial results.

What is National Health Investors’s dividend yield?

National Health Investors currently has a dividend yield of 5.20%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.